Skip links


Full Name Wainua
Drug Wainua
Manufacturer AstraZeneca
Route of Administration Subcutaneous
Site of Care Home
Approved Indication The treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults
Disease Hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN)
Therapeutic Area Neurology
Enrollment Form Link Wainua Enrollment Form
Phone Number 800-986-4975
Fax Number 877-369-5207
Product Website